A Randomized, Double-Blinded, Placebo-Controlled Multicenter Trial of Adenosine as an Adjunct to Reperfusion in the Treatment of Acute Myocardial Infarction (AMISTAD-II)

This publication has 39 references indexed in Scilit:

• Cardiac protection during acute myocardial infarction: Where do we stand in 2004?
  Journal of the American College of Cardiology, 2004
• Effect of Pexelizumab, an Anti-C5 Complement Antibody, as Adjunctive Therapy to Fibrinolysis in Acute Myocardial Infarction
  Circulation, 2003
• Myocardial salvage after coronary stenting plus abciximab versus fibrinolysis plus abciximab in patients with acute myocardial infarction: a randomised trial
  The Lancet, 2002
• Effect of 48-h intravenous trimetazidine on short- and long-term outcomes of patients with acute myocardial infarction, with and without thrombolytic therapy. A double-blind, placebo-controlled, randomized trial
  European Heart Journal, 2000
• Coronary Stenting plus Platelet Glycoprotein IIb/IIIa Blockade Compared with Tissue Plasminogen Activator in Acute Myocardial Infarction
  New England Journal of Medicine, 2000
• Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction
  Journal of the American College of Cardiology, 1999
• Assessment of Myocardial Viability in Chronic Coronary Artery Disease Using Technetium-99m Sestamibi SPECT:
  Journal of the American College of Cardiology, 1997
• Relation of initial infarct size to extent of left ventricular remodeling in the year after acute myocardial infarction
  Journal of the American College of Cardiology, 1995
• Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2)
  The Lancet, 1992
• Effect of intravenous adenosine on myocardial reperfusion injury in a model with low myocardial collateral blood flow
  American Heart Journal, 1991